Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Matsumotokiyoshi: Sales Up 1% but Operating Profits Down 0.9%
June 11, 2001
- Tokyo Women's Medical Univ. Introduces "MR-kun"
June 11, 2001
- Genzyme Aims at Leading Biosurgery Market
June 11, 2001
- New Quasi-drug Sales Up 8.5%, to \155.3 Bil.
June 11, 2001
- JKMA Proposes New Development for Kampo Medicines
June 11, 2001
- Boston Scientific Japan: Exxcel Soft, Artificial Blood Vessel
June 11, 2001
- WORLD NEWS IN BRIEF
June 11, 2001
- Mevalotin Inhibits Coronary Events, Cerebral Infarctions
June 11, 2001
- Sankyo to Cut Over \90 Bil. in Costs to Achieve Sales of \1,000 Bil. in FY2010: President Takato
June 11, 2001
- JPPA Kicks Off Division of Women
June 11, 2001
- 30 Major Domestic Drug Companies: Sales Up 2.1%, Profits Up 3.0%
June 11, 2001
- EAD Director Calls For Fair Trade Practices for Ethical Drugs
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
June 11, 2001
- Sankyo's Olmesartan More Effective than Other ARBs: Study
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
June 11, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
June 11, 2001
- Proposed Drug Classification Gives Top Priority to Clinical Usage
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -4-
June 11, 2001
- Implementation Working Group Formed for Coordinated Application of CTD
June 11, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…